Breast cancers that spread to the liver may change biology, impacting treatment effectiveness

ALK inhibitor shows high response rate in patients with advanced NSCLC harboring a specific gene alteration

New agent, eribulin, derived from marine sponge, increases survival among women with metastatic breast cancer

Antibody drug ipilimumab improves long-term survival in previously treated advanced melanoma

The role of genetic mutations in lung cancer

The use of monoclonal antibodies to treat mesothelioma

Tumour circulating cells

The use of targeted radiotherapy to treat lung cancer

Asbestos related diseases

Personalised treatment for lung cancer

Lung cancer treatment: new drugs and possibilities

The future of lung cancer treatment